Search results
Results from the WOW.Com Content Network
All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...
WHO reports that given community transmission the number of cases doubles every 1.5 to three days. The variant is now in 89 counties, and its severity profile remains unknown. [126] Seven to ten percent of new confirmed coronavirus cases in France are suspected to be of the Omicron variant and the travel ban on the UK comes into force. [127]
The world's first COVID-19 drug designed by generative AI is approved for human use, with clinical trials expected to begin in China. The new drug, ISM3312, is developed by Insilico Medicine. [389] A new AI algorithm developed by Baidu is shown to boost the antibody response of COVID-19 mRNA vaccines by 128 times. [390]
In September 2023, the FDA approved an updated a monovalent (single) component Omicron variant XBB.1.5 version of the vaccine (Spikevax 2023-2024 formula) as a single dose for individuals aged twelve years of age and older; [203] and authorized the Moderna COVID-19 Vaccine 2023-2024 formula under emergency use for individuals aged 6 months ...
It’s been nine months since Jennifer Haller, the first COVID vaccine tester, got a shot during Moderna’s Phase 1 trial. Now, Moderna and Pfizer's vaccine candidates are at the head of the race ...
The timeline of the COVID-19 pandemic lists the articles containing the chronology and epidemiology of SARS-CoV-2, [1] the virus that causes the coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 occurred in Wuhan, People's Republic of China, on or about 17 November 2019. [2]
President Donald Trump has suggested multiple times that a coronavirus vaccine could come within months, an accelerated timeline that prominent health experts and veteran vaccine developers say is ...
The potential emergence of a SARS-CoV-2 variant that is moderately or fully resistant to the antibody response elicited by the COVID-19 vaccines may necessitate modification of the vaccines. [452] The emergence of vaccine-resistant variants is more likely in a highly vaccinated population with uncontrolled transmission. [ 453 ]